InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,537.02
(
0.51%
)
US TECH 100
19,641.60
(
0.83%
)
Dow Jones
39,308.00
(
-0.06%
)
Brent Oil
87.33
(
0.48%
)
Bitcoin
57,106.92
(
-5.08%
)
Post# of 58465
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

RYJO

Send PM Follow Ignore
Followers 25
Posts 2553
Boards Moderated 0
Alias Born 08/10/2009

RYJO

Re: None

Thursday, 10/29/2009 7:56:58 PM

Thursday, October 29, 2009 7:56:58 PM

Post# of 58465
ATG Study

Abraxane helped more than without it.

What if these results are the knock em dead results that we were looking for from AGENDA?

I'm NOT implying that they will be knock em dead, I just want to know what would happen to PPS and the value of Genasense for partnership purposes, if either of these two OTHER clinical trials are knock em dead.

I appreciate all answers.
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up